Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: A position statement of the Canadian Cardiovascular Society

Acute coronary syndrome (ACS) guidelines recommend that most patients receive dual antiplatelet therapy with clopidogrel and acetylsalicylic acid (ASA) at the time of presentation to prevent recurrent ischemic events. Approximately 10% of ACS patients require coronary artery bypass grafting surgery...

詳細記述

保存先:
書誌詳細
主要な著者: Fitchett, David, Eikelboom, John, Fremes, Stephen, Mazer, David, Singh, Steve, Bittira, Bindu, Brister, Stephanie, Graham, John J, Gupta, Milan, Karkouti, Keyvan, Lee, Agnes, Love, Michael, McArthur, Rod, Peterson, Mark, Verma, Subodh, Yau, Terrence M
フォーマット: Artigo
言語:Inglês
出版事項: Pulsus Group Inc 2009
主題:
Canadian Cardiovascular Society Position Statement
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2807829/
https://ncbi.nlm.nih.gov/pubmed/19960127
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料